Stay updated on Pembrolizumab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Esophagogastric Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision advanced from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T20:51:42.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T03:49:15.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Access to the study page now displays a 403 Forbidden error instead of the study record content, blocking the trial details. The change replaces the page content with an error screen while keeping the site chrome visible.
    Difference
    18%
    Check dated 2026-09-21T22:30:03.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.5 to v3.6.6, reflecting a minor update to the document's metadata.
    Difference
    0.1%
    Check dated 2026-08-31T17:36:38.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Funding attribution for 2015 (NIH grant/contract) was added to the study record. This addition provides context about the funding source behind the trial.
    Difference
    0.1%
    Check dated 2026-08-24T19:15:52.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a minor administrative update to the page. This change does not modify the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-10T13:47:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.